Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations
Supported by

California Biotech Executive Faces Securities Fraud Charges

SACRAMENTO, Calif. (AP) — A former executive of a California biotech company faces federal conspiracy and fraud charges alleging that his actions misled investors.

An indictment unsealed Wednesday alleges that 47-year-old Hector Absi caused publicly traded Marrone Bio Innovations Inc. to falsely report that its revenue doubled from 2012 to 2013.

The Davis-based company develops and sells environmentally friendly pesticides.

Sponsor Message

Federal prosecutors say Absi hid unorthodox sales agreements and conspired with others to backdate deliveries to boost reported revenues. He received a performance-based bonus and exercised stock options based on the inflated figures.

The Securities and Exchange Commission filed a separate civil complaint against him.